(Q43902405)

27 November 2017

title

Reduced expression of reelin (RELN) gene is associated with high recurrence rate of hepatocellular carcinoma (English)

1 reference

27 November 2017

4

1 reference

27 November 2017

Yukiyasu Okamura

1

1 reference

27 November 2017

Shuji Nomoto

2

1 reference

27 November 2017

Mitsuro Kanda

3

1 reference

27 November 2017

Yoko Nishikawa

5

1 reference

27 November 2017

Tsutomu Fujii

6

1 reference

27 November 2017

Hiroyuki Sugimoto

7

1 reference

27 November 2017

Shin Takeda

8

1 reference

27 November 2017

Akimasa Nakao

9

1 reference

27 November 2017

publication date

24 August 2010

1 reference

Annals of Surgical Oncology

27 November 2017

published in

1 reference

27 November 2017

volume

18

1 reference

27 November 2017

issue

2

1 reference

27 November 2017

page(s)

572-579

1 reference

Global cancer statistics, 2002

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1273-Z

Registries in Japan: current status of hepatocellular carcinoma in Japan. Liver Cancer Study Group of Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1273-Z

Mutational hot spot in the p53 gene in human hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1273-Z

Loss of the gene encoding mannose 6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1273-Z

Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1273-Z

Quantitative monitoring of gene expression patterns with a complementary DNA microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1273-Z

Inhibition of endothelial cell chemotaxis toward FGF-2 by gefitinib associates with downregulation of Fes activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1273-Z

Leukemia inhibitory factor receptor (LIFR) is detected as a novel suppressor gene of hepatocellular carcinoma using double-combination array.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1273-Z

Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1273-Z

Role of the reelin signaling pathway in central nervous system development

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1273-Z

Reelin and brain development

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1273-Z

Differential and epigenetic gene expression profiling identifies frequent disruption of the RELN pathway in pancreatic cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1273-Z

Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1273-Z

Reelin promoter hypermethylation in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1273-Z

DNA methylation and chromatin - unraveling the tangled web.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1273-Z

Histone-deacetylase inhibitors: novel drugs for the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1273-Z

Evolving anticancer drug valproic acid: insights into the mechanism and clinical studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1273-Z

Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1273-Z

Association between Large-scale Genomic Homozygosity without Chromosomal Loss and Nonseminomatous Germ Cell Tumor Development

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1273-Z

10.1245/S10434-010-1273-Z

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

27 November 2017

1021442417

0 references

1 reference